| 27-Sep-12 |
| Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 25, 2012, have approved the proposal of appointment of Mr. P. V. Ramprasad Reddy as Executive Chairman of Aurobindo Pharma USA, Inc., the wholly owned subsidiary of the Company w.e.f. December 01, 2012. The said proposal is subject to further approval of the shareholders of the Company. Accordingly, an Extra Ordinary General Meeting of the Company is being convened on September 27, 2012. Consequent to his proposed appointment in the Company's US subsidiary, the Board has also approved Mr. Ramprasad Reddy relinquishing the executive responsibilities as Wholetime Director of the Company and his continuation as a Non-Executive Director of the Company not liable to retire by rotation with effect from December 01, 2012.
Bhageria Dye Chem Ltd has informed BSE that the 23rd Annual General Meeting (AGM) of the Company was held on September 01, 2012.
(As per BSE Announcement Dated on 03.09.2012)
Aurobindo Pharma Ltd has informed BSE regarding the details of Voting results at the Extra Ordinary General Meeting (EGM) of the Company held on September 27, 2012, under Clause 35A.
(As per BSE Announcement Dated on 28.09.2012)
|
| 23-Dec-10 |
| Aurobindo Pharma Ltd has informed BSE that an Extra Ordinary General Meeting (EGM) of the members of the Company will be held on December 23, 2010, inter alia, to Sub-division of 13,20,00,000 Equity Shares of the face value of Rs. 5/- each in the Authorised Share Capital of the Company into 66,00,00,000 Equity Shares of the face value of Rs. 1/- each.
Further to resolve that the existing Clause V of the Memorandum of Association of the Company relating to share capital be altered by deleting the same and substituting in place thereof the following new Clause V.
'V. a) The Authorised Share Capital of the Company is Rs. 76,00,00,000/- (Rupees Seventy Six Crores only) divided into 66,00,00,000 (Sixty Six Crores only) Equity Shares of Re.1/- (Rupee One only) each and 10,00,000 (Ten Lakhs only) Preference Shares of Rs. 100/- (Rupees One Hundred only) each.
b) The Company has power from time to time increase in Capital as Equity or preferred Shares and to attach to any class or classes of such Shares, preferences, rights, privileges or priorities in payment of dividends, or distribution of assets, or otherwise over and other shares and to subject the same to any restrictions, limitations or conditions and to vary the regulations of the Company, as to a portion the right to participate in profits in any manner subject to the prior consent of the Government of India or the order of the court, if the same will be necessary being obtained before doing so.
Further to resolve that the existing Article 3 of the Articles of Association of the Company relating to share capital be altered by deleting the same and substituting in place thereof the following new Article 3.
'3. The Authorised Share Capital of the Company is Rs. 76,00,00,000/- (Rupees Seventy Six Crores only) divided into 66,00,00,000 (Sixty Six Crores only) Equity Shares of Re. 1/- (Rupee One only) each and 10,00,000 (Ten Lakhs only) Preference Shares of Rs. 100/- (Rupees One Hundred only) each and the same may be increased or reduced in accordance with the Companies Act, 1956 and the Memorandum of Association as and when thought fit by the Board of Directors.'
Aurobindo Pharma Ltd has informed BSE that the shareholders at the Extraordinary General Meeting (EGM) of the Company held on December 23, 2010, have approved the sub-division of one equity share of the face value of Rs. 5/-each in the Company into five equity shares of the face value of Rs. 1/- each.
Aurobindo Pharma Ltd has submitted to BSE a copy of extract of the minutes of the Extra Ordinary General Meeting (EGM) of the Company held on December 23, 2010.
(As Per BSE Announcement Website Dated on 23/12/2010) |
| 20-Jan-10 |
| Aurobindo Pharma Ltd has informed BSE that by an order made on December 09, 2009, the Hon'ble High Court of Judicature of Andhra Pradesh at Hyderabad has directed that a Meeting of the Equity Shareholders of the Applicant Company i.e., Aurobindo Pharma Ltd., be convened and held on January 20, 2010, for the purpose of considering and if thought fit approving, with or without modification(s), the Scheme of Amalgamation proposed to be made between Trident Life Sciences Ltd. and Aurobindo Pharma Ltd. and their respective shareholders.
Aurobindo Pharma Ltd has informed BSE that the Shareholders of the Company at their meeting held on January 20, 2010, as per the directions of the Hon'ble High Court of Andhra Pradesh at Hyderabad, have approved the Scheme of Amalgamation between Trident Life Sciences Ltd. (a wholly owned subsidiary of Aurobindo Pharma Ltd.) and Aurobindo Pharma Ltd and their respective Shareholders.
(As Per BSE Announcement Website dated on 21.01.2010) |
| 21-May-09 |
| Aurobindo Pharma Ltd has informed the Exchange that by an order made on April 18, 2009 in the Company Application, the Hon'ble High Court of Judicature of Andhra Pradesh at Hyderabad has directed that a Meeting of the Equity Shareholders
of the Applicant Company i.e., Aurobindo Pharma Limited, be convened and held on May 21, 2009 for the purpose of considering and if thought fit approving, with or without modification(s), the arrangements embodied in the Scheme of Arrangement proposed to be made between Aurobindo Pharma Limited and its Shareholders.
Aurobindo Pharma Ltd has informed BSE that the Shareholders of the Company at its meeting held on May 21, 2009, as per the directions of the Hon'ble High Court of Andhra Pradesh at Hyderabad, have approved the Scheme of Arrangement between the Company and its Shareholders by requisite majority.
The Shareholders have also approved the resolution for the reduction of capital in the form of utilization of Capital Redemption Reserve Account as the proposed Scheme involves Utilization of the Capital Redemption Reserve Account and creation of Reconstruction Reserve Account.
(As Per BSE Announcement Website dated on 22.05.2009) |
| 20-Feb-07 |
| Aurobindo Pharma Ltd has informed BSE that pursuant to the order made by the High Court of Judicature of Andhra Pradesh, at Hyderabad, a meeting of the Equity Shareholders of the Company will be held on February 20, 2007, for the purpose of considering, and if thought fit, approving with or without modification(s), the arrangement embodied in the Scheme of Arrangement proposed to be made between the Company and APL Life Sciences Ltd and Senor Organics Pvt Ltd |